Skip to content

Acorda Therapeutics, Inc.: filings

Every Acorda Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 57 filings, each linked to its SEC index.

Filing record ends 2024-05-14

The latest filing in this captured record is a 10-Q filed 2024-05-14. No later filing is in the SEC companyfacts record captured on 2026-09-22. Acorda Therapeutics, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2024-05-14fiscal Q1 202443900000950170-24-059114
10-K2024-04-01fiscal FY 2023521060000950170-24-039464
10-Q2023-11-14fiscal Q3 2023461360000950170-23-063274
10-Q2023-08-09fiscal Q2 2023461310000950170-23-039975
10-Q2023-05-11fiscal Q1 202345920000950170-23-021373
10-K2023-03-15fiscal FY 2022521040000950170-23-007948
10-Q2022-11-14fiscal Q3 2022471380001564590-22-037510
10-Q2022-08-09fiscal Q2 2022471350001564590-22-028759
10-Q2022-05-13fiscal Q1 202247960001564590-22-020011
10-K2022-03-18fiscal FY 2021531060001564590-22-010971
10-Q2021-11-12fiscal Q3 2021471400001564590-21-056704
10-Q2021-08-12fiscal Q2 2021471360001564590-21-044034
10-Q2021-05-12fiscal Q1 202147990001564590-21-027047
10-K2021-03-16fiscal FY 2020531060001564590-21-013318
10-Q2020-11-06fiscal Q3 2020481410001564590-20-051662
10-Q2020-08-07fiscal Q2 2020481370001564590-20-038393
10-Q2020-05-08fiscal Q1 2020481000001564590-20-023661
10-K2020-02-28fiscal FY 2019551800001564590-20-007789
10-Q2019-11-07fiscal Q3 2019481360001564590-19-041866
10-Q2019-08-07fiscal Q2 2019481330001564590-19-029654
10-Q2019-05-07fiscal Q1 201947970001564590-19-016616
10-K2019-02-27fiscal FY 2018511630001564590-19-004986
10-Q2018-11-06fiscal Q3 2018421130001564590-18-027520
10-Q2018-08-08fiscal Q2 2018421140001564590-18-020171
10-Q2018-05-09fiscal Q1 201832670001564590-18-012112
10-K/A2018-03-09fiscal FY 2017441250001564590-18-005035
10-K2018-03-01fiscal FY 2017441250001564590-18-003967
10-Q2017-11-07fiscal Q3 201736980001564590-17-022347
10-Q2017-08-08fiscal Q2 201736990001564590-17-016602
10-Q2017-05-09fiscal Q1 201735710001564590-17-009938
10-K2017-02-27fiscal FY 2016441420001564590-17-002591
10-Q2016-11-07fiscal Q3 2016371040001008848-16-000136
10-Q2016-08-04fiscal Q2 2016391110001008848-16-000119
10-Q2016-05-06fiscal Q1 201636730001008848-16-000096
10-K2016-02-29fiscal FY 2015431400001008848-16-000076
10-Q2015-11-09fiscal Q3 2015371040001008848-15-000054
10-Q2015-08-07fiscal Q2 2015371040001008848-15-000038
10-Q2015-05-08fiscal Q1 201536730001008848-15-000022
10-K2015-02-27fiscal FY 2014421370001008848-15-000009
10-Q2014-11-07fiscal Q3 201434980001008848-14-000049
10-Q2014-08-07fiscal Q2 201434980001008848-14-000043
10-Q2014-05-09fiscal Q1 201434700001008848-14-000030
10-K2014-03-03fiscal FY 2013411350001008848-14-000011
10-Q2013-11-07fiscal Q3 201334970001008848-13-000086
10-Q2013-08-08fiscal Q2 201334970001008848-13-000063
10-Q2013-05-10fiscal Q1 201334690001008848-13-000043
10-K2013-02-28fiscal FY 2012411320001008848-13-000011
10-Q2012-11-08fiscal Q3 201235990001008848-12-000059
10-Q2012-08-08fiscal Q2 201233960001008848-12-000044
10-Q2012-05-09fiscal Q1 201233680001008848-12-000031
10-K2012-02-28fiscal FY 2011411370001008848-12-000015
10-Q2011-11-07fiscal Q3 201135980001008848-11-000082
10-Q2011-08-08fiscal Q2 201134960001008848-11-000067
10-Q2011-05-09fiscal Q1 201133680001008848-11-000037
10-K2011-03-01fiscal FY 201028750001008848-11-000018
10-Q2010-11-09fiscal Q3 201032880001008848-10-000036
10-Q2010-08-09fiscal Q2 201028720001008848-10-000019

Inspect the source

Entity
Acorda Therapeutics, Inc. / CIK 0001008848
Captured
SEC response SHA-256
c2d58bfc837ef6a6ec03ace43e8d0507ad0968fa8666de37eb863e1308c9b0d4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001008848.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))